IN2009DN05722A - - Google Patents
Download PDFInfo
- Publication number
- IN2009DN05722A IN2009DN05722A IN5722DEN2009A IN2009DN05722A IN 2009DN05722 A IN2009DN05722 A IN 2009DN05722A IN 5722DEN2009 A IN5722DEN2009 A IN 5722DEN2009A IN 2009DN05722 A IN2009DN05722 A IN 2009DN05722A
- Authority
- IN
- India
- Prior art keywords
- prostate cancer
- susceptibility
- determining
- variants
- methods
- Prior art date
Links
- 208000035392 hereditary 6 prostate cancer Diseases 0.000 abstract 3
- 208000032154 hereditary 8 prostate cancer Diseases 0.000 abstract 3
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8604 | 2007-02-07 | ||
| IS8654 | 2007-06-22 | ||
| PCT/IS2008/000003 WO2008096375A2 (en) | 2007-02-07 | 2008-02-07 | Genetic variants contributing to risk of prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009DN05722A true IN2009DN05722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-07-24 |
Family
ID=39650503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5722DEN2009 IN2009DN05722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2007-02-07 | 2008-02-07 |
Country Status (13)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697360B2 (en) | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
| WO2009085196A1 (en) * | 2007-12-21 | 2009-07-09 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9646134B2 (en) | 2010-05-25 | 2017-05-09 | The Regents Of The University Of California | Bambam: parallel comparative analysis of high-throughput sequencing data |
| CN106951732B (zh) | 2010-05-25 | 2020-03-10 | 加利福尼亚大学董事会 | 基于计算机的基因组序列分析系统 |
| WO2012029080A1 (en) * | 2010-08-30 | 2012-03-08 | Decode Genetics Ehf | Sequence variants associated with prostate specific antigen levels |
| EP2611943B1 (en) * | 2010-09-03 | 2017-01-04 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
| WO2013037118A1 (zh) * | 2011-09-16 | 2013-03-21 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| CN103060433B (zh) * | 2012-10-19 | 2014-12-03 | 卫生部北京医院 | 一种预测前列腺癌易感性的试剂盒和方法 |
| RU2669809C2 (ru) * | 2012-11-20 | 2018-10-16 | Пхадиа Аб | Способ прогноза для индивидуумов с раком предстательной железы |
| WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR101944927B1 (ko) | 2016-03-24 | 2019-02-07 | 서울대학교산학협력단 | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR102068667B1 (ko) * | 2019-02-28 | 2020-01-21 | 주식회사 프로카젠 | 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371654B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371655B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068666B1 (ko) * | 2019-02-28 | 2020-02-11 | 주식회사 프로카젠 | 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| CN110596060B (zh) * | 2019-09-12 | 2020-08-21 | 江南大学 | 一种检测前列腺特异性抗原的光谱分析中荧光传感器的构建方法及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| ATE98300T1 (de) | 1983-01-10 | 1993-12-15 | Gen Probe Inc | Verfahren zum aufspueren, identifizieren und quantifizieren von organismen und viren. |
| US5288611A (en) | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP1892296A1 (en) | 1988-09-02 | 2008-02-27 | Dyax Corporation | Generation and selection of recombinant varied binding proteins |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| JPH06508511A (ja) | 1990-07-10 | 1994-09-29 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的な結合ペアーの構成員の製造方法 |
| ES2113940T3 (es) | 1990-12-03 | 1998-05-16 | Genentech Inc | Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas. |
| CA2097708A1 (en) | 1990-12-06 | 1992-06-07 | Stephen P. A. Fodor | Very large scale immobilized polymer synthesis |
| DK1279731T3 (da) | 1991-03-01 | 2007-09-24 | Dyax Corp | Fremgangsmåde til udvikling af bindende miniproteiner |
| ES2315612T3 (es) | 1991-04-10 | 2009-04-01 | The Scripps Research Institute | Genotecas de receptores heterodimericos usando fagemidos. |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| EP0695941B1 (en) | 1994-06-08 | 2002-07-31 | Affymetrix, Inc. | Method and apparatus for packaging a chip |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| EP1736554B1 (en) | 1996-05-29 | 2013-10-09 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US5925519A (en) * | 1996-06-03 | 1999-07-20 | The Regents Of The University Of California | Genetic alterations associated with prostate cancer |
| WO1999064590A1 (en) * | 1998-06-05 | 1999-12-16 | Genset | Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| US6355623B2 (en) | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| US6844189B1 (en) * | 1998-11-06 | 2005-01-18 | Myriad Genetics, Inc. | Chromosome 17P-linked prostate cancer susceptibility gene |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| AU2003276973A1 (en) * | 2002-09-25 | 2004-04-19 | Amersham Biosciences (Sv) Corp. | Detection methods |
| US20050136407A1 (en) * | 2003-12-19 | 2005-06-23 | Cramer Scott D. | Genetic polymorphisms in the prostate-specific antigen gene promoter |
| US20050255507A1 (en) * | 2004-02-17 | 2005-11-17 | Jenkins Robert B | Cytogenetically determined diagnosis and prognosis of proliferative disorders |
| WO2006063285A2 (en) * | 2004-12-10 | 2006-06-15 | Sequenom, Inc. | Methods for identifying risk of breast cancer or prostate cancer and treatments thereof |
| BRPI0610794A2 (pt) | 2005-05-18 | 2010-11-09 | Decore Genetics Ehf | métodos para diagnosticar uma susceptibilidade a um cáncer e para predizer um risco aumentado de cáncer, kit para ensaiar uma amostra de um indivìduo para detectar uma susceptibilidade a um cáncer, e, métodos para diagnosticar um risco aumentado de cáncer e para diagnosticar um cáncer associado com chr8q24.21 |
| JP5631000B2 (ja) | 2006-10-27 | 2014-11-26 | デコード・ジェネティクス・イーエイチエフ | Ｃｈｒ８ｑ２４．２１上の癌感受性変異体 |
| US8697360B2 (en) | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
-
2008
- 2008-02-07 IN IN5722DEN2009 patent/IN2009DN05722A/en unknown
- 2008-02-07 US US12/442,171 patent/US8865400B2/en not_active Expired - Fee Related
- 2008-02-07 BR BRPI0807236A patent/BRPI0807236A2/pt not_active IP Right Cessation
- 2008-02-07 SG SG2012008371A patent/SG193026A1/en unknown
- 2008-02-07 NZ NZ579401A patent/NZ579401A/en not_active IP Right Cessation
- 2008-02-07 MX MX2009008461A patent/MX2009008461A/es active IP Right Grant
- 2008-02-07 CN CN2008800107105A patent/CN102317470A/zh active Pending
- 2008-02-07 WO PCT/IS2008/000003 patent/WO2008096375A2/en active Application Filing
- 2008-02-07 CA CA002677994A patent/CA2677994A1/en not_active Abandoned
- 2008-02-07 JP JP2009548801A patent/JP2010520745A/ja not_active Ceased
- 2008-02-07 EP EP12160294.0A patent/EP2522743A3/en not_active Withdrawn
- 2008-02-07 EP EP08710289.3A patent/EP2115171B1/en active Active
- 2008-02-07 AU AU2008212117A patent/AU2008212117B2/en not_active Ceased
-
2009
- 2009-08-02 IL IL200197A patent/IL200197A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102317470A (zh) | 2012-01-11 |
| EP2522743A2 (en) | 2012-11-14 |
| US20100041037A1 (en) | 2010-02-18 |
| AU2008212117B2 (en) | 2014-09-11 |
| EP2522743A3 (en) | 2013-08-07 |
| JP2010520745A (ja) | 2010-06-17 |
| US8865400B2 (en) | 2014-10-21 |
| WO2008096375A3 (en) | 2008-12-18 |
| EP2115171A2 (en) | 2009-11-11 |
| NZ579401A (en) | 2012-03-30 |
| BRPI0807236A2 (pt) | 2019-09-24 |
| MX2009008461A (es) | 2009-08-17 |
| WO2008096375A2 (en) | 2008-08-14 |
| IL200197A (en) | 2014-07-31 |
| SG193026A1 (en) | 2013-09-30 |
| EP2115171B1 (en) | 2015-01-21 |
| IL200197A0 (en) | 2010-04-29 |
| AU2008212117A1 (en) | 2008-08-14 |
| CA2677994A1 (en) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009DN05722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| GB2460769A (en) | Tle3 as a marker for chemotherapy | |
| AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
| MX340453B (es) | Biomarcadores para cancer de pulmon. | |
| MX340181B (es) | Plantas de pepino resistentes al mildiu velloso. | |
| ATE522518T1 (de) | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe | |
| MX2014002208A (es) | Inhibidores de serina/treonina quinasa. | |
| MX2011013243A (es) | Marcadores de riesgo para enfermedad cardiovascular. | |
| WO2009134487A3 (en) | Optimized methods for delivery of dsrna targeting the pcsk9 gene | |
| PT1893196E (pt) | Composto de diaril-hidantoína | |
| MY150542A (en) | Cmet inhibitors | |
| MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
| MX2011011431A (es) | Composicion para el tratamiento de cancer de prostata. | |
| EP2516624A4 (en) | CELL LINE 3M | |
| MX2009007695A (es) | Compuestos complejos de carbohidrato de hierro. | |
| MY156954A (en) | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES | |
| WO2012083969A3 (en) | Microrna for diagnosis of pancreatic cancer | |
| MX2009004167A (es) | Anticuerpos que enlazan epitopos cxcr7. | |
| MX337203B (es) | Novedosas moleculas inhbidoras de jnk. | |
| MX339300B (es) | Inhibidores de molecula pequeña de la activacion n-terminal del receptor de androgenos. | |
| IN2014KN01062A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| MX2014006187A (es) | Composiciones y metodos para el analisis de cancer de prostata. | |
| MX2009006943A (es) | Procedimiento para la mejor utilizacion del potencial de produccion de plantas transgenicas. | |
| PH12012501153A1 (en) | Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds | |
| PL2099812T3 (pl) | Sposób wytwarzania tagatozy z wykorzystaniem izomeryzacji galaktozy o wysokiej wydajności |